Clinical trials for Herceptin

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Herceptin. For all clinical trials, go to clinical trials search

This list shows clinical trials for Herceptin

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Herceptin
Title Recruitment status Location
A PHASE III PROSPECTIVE, TWO-COHORT NON-RANDOMIZED, MULTI-CENTRE, MULTINATIONAL, OPEN LABEL STUDY TO ASSESS THE SAFETY OF ASSISTED- AND SELF-ADMINISTERED SUBCUTANEOUS TRASTUZUMAB AS THERAPY IN PATIENTS WITH OPERABLE HER2-POSITIVE EARLY BREAST CANCER [SafeHer Study] Recruiting United Kingdom
An Extension Study of Trastuzuma Emtansine in Patients Previously Treated With Trastuzuma Emtansine Recruiting United Kingdom
Phase IIIb Study to Evaluate the Safety and Tolerability of Herceptin SC With Perjeta and Docetaxel in Patients With HER2-positive Advanced Breast Cancer Recruiting United Kingdom
First-in-human Study With the Antibody-drug Conjugate SYD985 to Evaluate Safety and Efficacy in Cancer Patients Recruiting United Kingdom
Effect of Peri-operative anti-HER2 therapy On early breast cancer Study - Biological phase Recruiting United Kingdom
A Study to Assess the Efficacy and Safety of Enzalutamide With Trastuzumab in Subjects With Human Epidermal Growth Factor Receptor 2 Positive (HER2+), Androgen Receptor Positive (AR+) Metastatic or Locally Advanced Breast Cancer Recruiting United Kingdom
Trastuzumab or Lapatinib Ditosylate in Treating Women With Early Breast Cancer Recruiting United Kingdom
Planning Treatment for Oesophago-gastric Cancer: a Maintenance Therapy Trial Recruiting United Kingdom
Persephone: duration of herceptin with chemotherapy 6 versus 12 months Recruiting United Kingdom
Comparative trial to evaluate the efficacy and safety of antibody treatment in patients with early breast cancer Recruiting United Kingdom

Page last reviewed:

Next review due: